Brief: Asit Biotech Plans To Raise EUR 9 mln -12 Mln To Finance Focused Development

European Medical Solutions SA

01/07/2019 06:10

July 1 (Reuters) - Asit Biotech SA  ASIT.BR :
    * ASIT BIOTECH CONTINUES ITS TRANSFORMATION FROM RESEARCH TO LATE STAGE
CLINICAL
DEVELOPMENT
    * COMPANY SHAREHOLDERS APPROVE ALL MOTIONS AT EXTRAORDINARY GENERAL MEETING
    * FIRM EXPECTS TO RAISE EUR 9-12 M TO FINANCE FOCUSED DEVELOPMENT
    * JEAN-PAUL PRIEELS CONFIRMED AS NEW MEMBER OF BOARD OF DIRECTORS
    * PHASE III ON TRACK AND SUCCESSFUL INTERNALIZATION OF ASIT'S BIOTECH
CLINICAL
PRODUCTION CAPABILITY
    * COMPANY SHOULD HAVE SUFFICIENT FINANCIAL RESOURCES TO SUPPORT ITS PLANNED
DEVELOPMENT UNTIL Q3 OF 2020

Source text for Eikon:  ID:nBw3sV4D7a 
Further company coverage:  ASIT.BR 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))